Skip to main content

Advertisement

Table 1 Patient demographics, immunosuppressive treatments and disease characteristics at the time of interview

From: Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis

Gender Age (years) Diagnosis Duration of arthritis / uveitis (years) Previous treatment Treatment at time of interview Active joints Uveitis complications Ophthalmic surgery Eye Visual acuity (LogMAR) Anterior chamber cells (SUN grade)
M 6 Extended oligo JIA Left anterior uveitis 6 / 3.5 TS, MTX sc, ETA (stopped after onset of uveitis), ADA MTX sc, ADA nil Posterior synechiae, cataract, band keratopathy Orbital floor steroid injection RE 0.000 0
LE 0.150 0.5
F 7 RF-ve poly JIA Bilateral anterior uveitis 5 / 1.5 TS, MTX sc MTX sc, ADA nil Glaucoma Nil RE 0.000 0
LE 0.050 0
F 7 Persistent oligo JIA Bilateral anterior uveitis 2 / 2 TS, MTX sc TS, MTX sc nil nil nil RE −0.100 0
LE −0.100 0
F 10 Extended oligo JIA Bilateral anterior uveitis 5 / 5 TS, IVMP, MTX, MMF, INF, ADA TS, MMF, ADA nil Posterior synechiae cataract, glaucoma Cataract surgery BE, glaucoma surgery BE RE 0.075 0
LE 0.025 0.5
F 10 RF-ve poly JIA Bilateral anterior uveitis 9 / 5 TS, MTX sc, IVMP, INF, MMF, ADA TS, MTX sc, ADA Left ankle Posterior synechiae, cataract, glaucoma, CMO, band keratopathy Cataract surgery BE, Trabeculectomy BE RE 0.125 0.5
LE 0.175 0.5
M 13 RF-ve poly JIA Bilateral anterior uveitis >8 / 6 IVMP, INF, MTX sc, ADA, MMF, ABA MTX, MMF, ABA nil Posterior synechiae, cataract Cataract surgery RE RE 0.050 2
LE −0.100 3
F 14 Extended oligo JIA Bilateral anterior uveitis >8 / >8 TS, MTX sc, INF TS, MTX sc, ADA Left hip, right knee Cataract, glaucoma Cataract surgery BE, glaucoma surgery BE RE −0.100 0.5
LE HM 0.5
M 16 Blau syndrome Bilateral panuveitis 15 / 8 TS, MTX sc, ADA TS, MTX sc, MMF, IVMP, INF nil Posterior synechiae, cataract, chorioretinal scars, vitritis nil RE 0.850 1
LE 0.100 1
M 16 Psoriatic JIA Bilateral anterior uveitis >8 / >8 MTX sc, INF MTX sc, ADA nil nil nil RE 0.000 0
LE −0.075 0
M 17 Extended oligo JIA Bilateral panuveitis 9 / 8 TS, MTX sc TS, MTX sc nil Cataract, glaucoma ST steroid injection RE RE 0.125 0.5
LE −0.200 2
  1. Legend: ABA Abatacept, ADA Adalimumab, BE Both eyes, CMO, Cystoid macular oedema, ETA Etanercept, HM Hand motion, INF Infliximab, IVMP Intravenous methylprednisolone, JIA Juvenile idiopathic arthritis, LE Left eye, MMF Mycophenolate mofetil, MTX Methotrexate, oligo Oligoarticular, poly Polyarticular, RE Right eye, RF Rheumatoid factor, sc Subcutaneously, ST Sub-Tenon’s capsule, SUN Standardisation of Uveitis Nomenclature, TS Topical steroids